David Lembo
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
Papers in
- Epidemiology 64
- Herpesvirus Infections and Treatments 29
- Cytomegalovirus and herpesvirus research 26
- Respiratory viral infections research 8
-
- Viral gastroenteritis research and epidemiology 10
- Co-authors
- Andrea Civra (63 shared papers)Roberta Cavalli (27 shared papers)Manuela Donalisio (60 shared papers)Santo Landolfo (30 shared papers)Valeria Cagno (27 shared papers)Giorgio Gribaudo (13 shared papers)Marisa Gariglio (13 shared papers)Rachele Francese (24 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (8 papers)Antiviral Research (8 papers)Journal of Virology (7 papers)PLoS ONE (5 papers)Frontiers in Pediatrics (4 papers)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
David Lembo
141 papers receiving 5.1k citations
David Lembo's Hit Papers
Peers
Comparison fields: 5 of 150
- Pharmaceutical Science 367
- Infectious Diseases 929
- Epidemiology 1.3k
- Virology 191
- Immunology 778
Countries citing papers authored by David Lembo
This map shows the geographic impact of David Lembo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Lembo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Lembo more than expected).
Fields of papers citing papers by David Lembo
This network shows the impact of papers produced by David Lembo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Lembo. The network helps show where David Lembo may publish in the future.
Co-authors
The 25 scholars most cited alongside David Lembo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 149 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism Hit paper breakdown → | 2017 | 361 |
| 2 | 2003 | 267 | |
| 3 | 2010 | 172 | |
| 4 | 2012 | 167 | |
| 5 | 2018 | 159 | |
| 6 | Silver Nanoparticles: Review of Antiviral Properties, Mechanism of Action and Applications Hit paper breakdown → | 2023 | 153 |
| 7 | 2017 | 146 | |
| 8 | 2008 | 118 | |
| 9 | 2009 | 117 | |
| 10 | 2019 | 104 | |
| 11 | 2014 | 100 | |
| 12 | 2016 | 98 | |
| 13 | 2012 | 96 | |
| 14 | 1998 | 95 | |
| 15 | 2016 | 92 | |
| 16 | 2013 | 85 | |
| 17 | 2020 | 84 | |
| 18 | 2009 | 82 | |
| 19 | 2009 | 79 | |
| 20 | 2004 | 77 |
About David Lembo
David Lembo is a scholar working on Epidemiology, Infectious Diseases, Immunology, Virology and Oncology, having authored 149 papers that have together received 5.3k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (29 papers), Cytomegalovirus and herpesvirus research (26 papers), interferon and immune responses (16 papers), Cholesterol and Lipid Metabolism (11 papers), HIV Research and Treatment (10 papers), Viral gastroenteritis research and epidemiology (10 papers), RNA Interference and Gene Delivery (9 papers) and Respiratory viral infections research (8 papers). The work is most often cited by research in Pharmaceutical Science (367 citations), Infectious Diseases (929 citations), Epidemiology (1.3k citations), Virology (191 citations) and Immunology (778 citations). David Lembo has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Andrea Civra, Roberta Cavalli, Manuela Donalisio, Santo Landolfo, Valeria Cagno, Giorgio Gribaudo, Marisa Gariglio, Rachele Francese, Wolfram Brune and Agnese Bisazza. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Antiviral Research, Journal of Virology, PLoS ONE and Frontiers in Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.